> As part of its restructuring, NPS Pharmaceuticals has sold its Salt Lake City facility to the University of Utah for $21 million. Report
> The National Institute for Health and Clinical Excellence in England has endorsed Tysabri for MS patients. Release
> The FDA has added a black box warning to Genentech's Xolair for asthma. Report
> Novartis says it will increase its U.S. supply of Fluvirin flu vaccine by 30 percent to 40 percent. Report
> The FDA has approved Tamiflu in 30 mg and 45 mg. Report
> Patients with inoperable non-small cell lung cancer who receive an initial high dose of chemotherapy before their treatment begins can expect an increase in overall survival, according to a new study. Release
> In a remarkable breakthrough for weight research, scientists have reported the discovery of a neurochemical pathway that stimulates the accumulation of fat in animals laboring under chronically high stress and exposed to a diet of junk food. Report
> The heart drug propranolol can be used to interfere with the way the brain stores memories, offering a new approach to treating people with post traumatic stress disorder. Report
And Finally... The first half of 2007 has been tough for biotech stocks. Report